- New phthalimide-benzamide-1,2,3-triazole hybrids; design, synthesis, α-glucosidase inhibition assay, and docking studySeyed Esmaeil, Sadat-Ebrahimi; Abbas, Rahmani; Maryam, Mohammadi-Khanaposhtani; Negar, jafari; Somayeh, Mojtabavi; Mohammad, Ali Faramarzi; Mehdi, Emadi; Azadeh, Yahya-Meymandi; Bagher, Larijani; Mahmoud, Biglar; Mohammad, MahdaviMEDICINAL CHEMISTRY RESEARCH, 2020, 29(5): 868-876.被引 1
- Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studiesMohammad Sadegh, Asgari; Maryam, Mohammadi-Khanaposhtani; Zeinab, Sharafi; Mohammad Ali, Faramarzi; Hossein, Rastegar; Ensieh, Nasli Esfahani; Fatemeh, Bandarian; Parviz, Ranjbar Rashidi; Rahmatollah, Rahimi; Mahmood, Biglar; Mohammad, Mahdavi; Bagher, LarijaniMOLECULAR DIVERSITY, 2020.
- Feasibility of Structural Modification of Retinoid X Receptor Agonists to Separate Blood Glucose-Lowering Action from Adverse Effects: Studies in KKAy Type 2 Diabetes Model MiceHiroki Kakuta; Fuminori Ohsawa; Shoya Yamada; Makoto Makishima; Akihiro Tai; Hiroyuki Yasui; Yutaka YoshikawaBiological and Pharmaceutical Bulletin, 2012, 35(4): 629-633.
期刊论文
Glycogen Phosphorylase a Inhibitors with a Phenethylphenylphthalimide Skeleton Derived from Thalidomide-Related .ALPHA.-Glucosidase Inhibitors and Liver X Receptor Antagonists
6被引19阅读
